Freeze dried ondansetron: First observations with the fast dissolving oral antiemetic Zofran™ Zydis™ for the prophylaxis of the cisplatin-induced emesis in gynecological cancer patients

Neoplasma

Volumn 49, Issue 2, 2002, Pages 126-128

  Lehoczky, O ^a   Udvary, J ^a   Pulay, T ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

Author keywords

Antiemesis; Chemotherapy; Cisplatin; Fast dissolving ondansetron; Gynecological cancer; Setrons

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; OLANZAPINE; ONDANSETRON;

ADULT; AGED; ARTICLE; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; DISPERSION; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; DRUG SOLUBILITY; FEMALE; FREEZE DRYING; GYNECOLOGIC CANCER; HUMAN; SALIVA; SWALLOWING; TABLET DISINTEGRATION;

EID: 0036247325     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis
2. Oral ondansetron 8 mg twice daily is as effective as 8 mg three times daily in the prevention of nausea and vomiting associated with moderately emetogenic cancer chemotherapy
3. Single 8 mg dose of oral ondansetron failed to prevent FAC chemotherapy-induced acute nausea and vomiting
4. Methylprenisolone enhances the efficacy of ondansetron in acute and delayed cisplatin-induced emesis over at least three cycles
5. Oral ondansetron in the prevention of chemotherapy-induced emesis in breast cancer patients
6. Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study
7. Ondansetron suppository: An effective treatment for the prevention of emetic disorders induced by cisplatin-based chemotherapy
8. Randomised, multicenter comparison of oral granisetron and oral ondansetron for emetogenic chemotherapy
9. Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients
10. A multicenter, double-blind comparison of i.v. and oral administration of ondansetron plus dexamethasone for acute cisplatin-induced emesis
11. Efficacy of an ondansetron orally disintegrating tablet: A novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis
12. The antiemetic efficacy of oral ondansetron plus intravenous dexamethasone in patients with gynecologic malignancies receiving carboplatin-based chemotherapy
13. A multicenter, double-blind, randomised comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy
14. Ondansetron
15. Drug-delivery products and the Zydis fast-dissolving dosage form
16. A comparison of oral ondansetron and intravenous granisetron for the prevention of nausea and emesis associated with cisplatin-based chemotherapy
17. A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in paediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy